Novartis AG raised its full-year guidance Wednesday as it reported strong growth of its newer drugs, bolstering its chief executive’s efforts to focus the pharmaceutical giant on higher-value medicines.
The Basel, Switzerland-based company said it now expects core operating income to grow by a high single-digit percentage, up from earlier guidance of a mid-to-high single digit rise. It said it continued to expect sales to increase by a mid-single-digit percentage.
Revamping his annual bonus.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US stocks rally again to record highs as earnings smash expectations — 'Is it different this time?'Better-than-expected earnings unleashed a wave of optimism in the US, sending the S&P 500 to its 'third big high.' Asia and Europe weren't as upbeat. When the “is it different this time?” stories start it is time to het your money out because a crash is around the corner 'earnings smash expectations'. Whose earnings? The 99%ers'?
Source: BusinessInsider - 🏆 729. / 51 Read more »
European shares dip as China policy concerns temper earnings boostEuropean shares pulled back from eight-month highs on Wednesday as worries over ...
Source: Reuters - 🏆 2. / 97 Read more »
Caterpillar is set to report earnings before the bell — here's what the Street expectsCaterpillar is reporting first-quarter earnings before the bell on Wednesday.
Source: CNBC - 🏆 12. / 72 Read more »
Boeing earnings expected before the bell as market looks for 737 Max newsBoeing's first-quarter earnings report is expected before the market opens on Wednesday.
Source: CNBC - 🏆 12. / 72 Read more »